Infection Intel

November 27th 2023

GigaGen, a biotech company, secures an $11.8M contract expansion with the US Department of Defense to develop synthetic human antibody treatments for botulinum neurotoxins.

November 24th 2023

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending November 25, 2023.

November 17th 2023

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending November 19, 2023.

November 14th 2023

Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.